Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: September 12, 2009
Last updated: August 6, 2013
Last verified: September 2009

RATIONALE: Women who do not undergo routine cervical screening may be more likely to collect a self-sample for human papillomavirus testing.

PURPOSE: This randomized clinical trial is studying self-sampling in women who do not undergo routine cervical screening.

Condition Intervention
Health Status Unknown
Precancerous Condition
Behavioral: compliance monitoring
Other: cervical Papanicolaou test
Other: educational intervention
Other: screening questionnaire administration
Other: survey administration
Procedure: colposcopy

Study Type: Observational
Official Title: The Potential Role of Self-sampling in Women Who do Not Attend for Cervical Screening - a Randomised Controlled Trial

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Comparison of the percentages of women responding to the invitation to return a self-sampling kit vs responding to an invitation for a cervical smear

Secondary Outcome Measures:
  • Response to the invitation for further investigation following a positive test result (colposcopy for women with a smear showing mild dyskaryosis or above, smear +/- colposcopy for those with a positive HPV test)
  • Response to the request to return a survey regarding demographic information and reasons for previous non-attendance for screening

Estimated Enrollment: 3000
Study Start Date: June 2009
Study Completion Date: March 2011
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Detailed Description:


  • To ascertain whether women who do not attend for cervical screening are more likely to respond to the opportunity to collect a self-sample for human papillomavirus (HPV) testing, or to respond to a further invitation to undergo a cervical smear.
  • To ascertain whether such women will attend for further investigation if they have a positive screening test (HPV test or cervical smear).

OUTLINE: Patients are randomized to 1 of 2 arms.

  • Control: Patients receive an invitation for a routine cervical smear and a cervical screening survey. Information regarding attendance for smear or colposcopy is collected at the Primary Care Trust.
  • Study (self-sampling kit): Patients receive an explanatory letter, an information sheet about the study, a consent form, information about human papillomavirus (HPV) and HPV testing, a self-sampling test kit, and an invitation to take their own HPV sample and return it to the research group for processing. Patients also receive a cervical screening survey. Patients who attend for further investigation following a positive HPV result go to St. Mary's Hospital Colposcopy Unit, Paddington. During this visit cervical smear tests are performed and women are offered immediate colposcopy so that they would not need to return for colposcopic examination if their smear test is abnormal.

This study is peer reviewed and funded or endorsed by cancer research UK.


Ages Eligible for Study:   25 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes


  • Women in Westminster Primary Care Trust (PCT) area eligible for routine cervical screening who have not responded to two invitations to attend for smears
  • No women who have written to the PCT to document their refusal to take part in the National Health Service Cervical Screening Program (NHSCSP)
  • No women who are not due for routine screening as part of the NHSCSP


  • Not pregnant
  • Have been sexually active


  • No prior total abdominal hysterectomy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00977392

United Kingdom
Barts and the London School of Medicine
London, England, United Kingdom, SW15 5PN
Sponsors and Collaborators
Barts and the London School of Medicine and Dentistry
Principal Investigator: Anne Szarewski, MD Queen Mary University of London
  More Information

Additional Information: Identifier: NCT00977392     History of Changes
Other Study ID Numbers: CRUK-Westminster-Self-Sampling
CDR0000648274 ( Registry Identifier: PDQ (Physician Data Query) )
ISRCTN40182307 ( Registry Identifier: ISRCTN (International Standard Randomised Controlled Trial Number Register) )
Study First Received: September 12, 2009
Last Updated: August 6, 2013

Keywords provided by National Cancer Institute (NCI):
human papilloma virus infection
health status unknown

Additional relevant MeSH terms:
Precancerous Conditions
Neoplasms processed this record on April 24, 2017